Phase 1/2 dose-escalation study of a GM-CSF-secreting, allogeneic, cellular immunotherapy for metastatic hormone-refractory prostate cancer (Q39958481)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 1/2 dose-escalation study of a GM-CSF-secreting, allogeneic, cellular immunotherapy for metastatic hormone-refractory prostate cancer |
scientific article |
Statements
1 reference
Phase 1/2 dose-escalation study of a GM-CSF-secreting, allogeneic, cellular immunotherapy for metastatic hormone-refractory prostate cancer (English)
1 reference
Celestia S Higano
1 reference
John M Corman
1 reference
David C Smith
1 reference
Arthur S Centeno
1 reference
Christopher P Steidle
1 reference
Marc Gittleman
1 reference
Jonathan W Simons
1 reference
Natalie Sacks
1 reference
Junko Aimi
1 reference
Eric J Small
1 reference
1 September 2008
1 reference
1 reference
Identifiers
1 reference